Harrow (HROW) Net Cash Flow Growth (3y) (2013 - 2026)
Harrow (HROW) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 32.03% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 28.99% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -49.94% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -41.05% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -62.71% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -205.66% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -59.10% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 36.11% |
| 10 | Harrow | 1.25 Bn | 1.15 Bn | 27.05 Mn | 31.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.65% |
| Dec 31, 2025 | -26.55% |
| Sep 30, 2025 | 154.17% |
| Jun 30, 2025 | -71.74% |
| Mar 31, 2025 | 349.70% |
| Dec 31, 2024 | -17.35% |
| Sep 30, 2024 | 28.24% |
| Jun 30, 2024 | -66.79% |
| Mar 31, 2024 | -65.32% |
| Dec 31, 2023 | 99.53% |
| Sep 30, 2023 | 197.66% |
| Jun 30, 2023 | 444.42% |
| Mar 31, 2023 | -353.65% |
| Dec 31, 2022 | 238.92% |
| Sep 30, 2022 | -38.06% |
| Jun 30, 2022 | 300.75% |
| Mar 31, 2022 | 56.01% |
| Dec 31, 2021 | -217.47% |
| Sep 30, 2021 | -107.94% |
| Jun 30, 2021 | 273.05% |